Article
Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Jun 2023
Rao Wen, Yang Lujie, Dai Nan, Zhang Liang, Liu Jie, Yang Bo, Li Mengxia, Shan Jinlu, Wang Qiushi, Wang Dong
Abstract excerpt
PURPOSE: Approximately, 45-65% stage I non-small cell lung cancer (NSCLC) patients with surgical resection relapse within 5 years. Therefore, it is urgent to identify the predictors involved in the relapse of stage I NSCLC. METHODS/PATIENTS: Targeted sequencing was used to examine the mutation of tumor tissues and matched adjacent normal tissues from 35 patients with stage I lung adenocarcinoma (LUAD). Then,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.